DSM (Parsippany NJ) and Taiyo Kagaku Co Ltd (Taiyo) entered into a licensing deal, effective July 1, 2014, transferring the entirety of the Teavigo^® brand EGCG business to Taiyo, reported the manufacturer.

Under terms of the deal, Taiyo will become the sole producer of Teavigo. Teavigo brand EGCG was formerly distributed under a license ftp, Pharmachem Laboratories, Inc. in the Dietary Supplement segment and by DSM in the Food and Beverage segments. Under terms of the agreement, Taiyo will take responsibility for all customer segments, globally, according to DSM.

“DSM appreciates its historical relationship with Pharmachem on Teavigo and the great job they did in the Dietary Supplement segment,” said Will Black, vice president of marketing, DSM. “We are delighted that Taiyo has taken over the Teavigo business. Taiyo’s solid reputation, extensive product portfolio, knowledge of the market and global reach make them a perfect fit for the Teavigo business.”

During the transitional period, DSM, Pharmachem and Taiyo, will collectively work together to allow for an orderly transition for all Teavigo customers and are dedicated to assure an uninterrupted supply, reported DSM.

For more information visit www.dsm.com.